Science Explorer Back to mapMap
Discussion
Researcher · Karo Pharma (Sweden) · Sweden

Mathias Färnegårdh

Mathias Färnegårdh publishes mostly in Molecular Biology, Endocrinology, Diabetes and Metabolism and Oncology, on topics such as Estrogen and related hormone effects, Drug Transport and Resistance Mechanisms and Cholesterol and Lipid Metabolism.

OpenAlex
World rank
#2,474,625
of 7,710,434 ranked researchers
Rank in Sweden
#31,838
of 71,437
Works
28
Citations
1.6k
Citations per work
56.3
h-index
17
i10-index 17Top 42% in Molecular Biology

What does Mathias Färnegårdh research?

Mathias Färnegårdh's work is mostly in Medicine (42%), Biochemistry, Genetics and Molecular Biology (33%), Neuroscience (5%).

Life Sciences39%Health Sciences42%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1242.1%
    1. Biochemistry, Genetics and Molecular Biology933.3%
    2. Neuroscience15.3%
  1. Everything else519.3%
  1. 1Molecular Biology19% of their works
  2. 2Endocrinology, Diabetes and Metabolism19% of their works
  3. 3Oncology14% of their works
  4. 4Genetics14% of their works
  5. 5Surgery9% of their works
  6. 6Cellular and Molecular Neuroscience5% of their works

Research topics

Which keywords describe Mathias Färnegårdh's research?

The keywords of their largest research topics: Nuclear Receptors, Estrogen, Metabolism, Receptor, ATP-dependent Transporters, Multidrug Resistance, Atherosclerosis and Cholesterol.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Nuclear Receptors183 topics
  2. Estrogen81 topic
  3. Metabolism82 topics
  4. Receptor81 topic
  5. ATP-dependent Transporters71 topic
  6. Multidrug Resistance71 topic
  7. Atherosclerosis51 topic
  8. Cholesterol51 topic
  9. Thyroid Dysfunction41 topic
  10. Thyroid Hormone41 topic
  11. Acute Promyelocytic Leukemia31 topic
  12. Aldosterone31 topic
  13. Dioxygen Activation31 topic
  14. IGF-131 topic
  15. Insulin-like Growth Factors31 topic
  16. Metalloenzyme31 topic
  17. Primary Aldosteronism31 topic
  18. Retinoic Acid31 topic

Where does Mathias Färnegårdh work?

Mathias Färnegårdh's main affiliation in the publication record is Karo Pharma (Sweden), Sweden.

How many publications and citations does Mathias Färnegårdh have?

OpenAlex counts 28 works and 1,576 citations for Mathias Färnegårdh, an h-index of 17, ranking #2,474,625 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Mathias Färnegårdh. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.